Managing heavy menstrual bleeding in adolescents with bleeding disorders: Outcomes from a pragmatic LMIC approach
Blood Cells, Molecules, and Diseases · 2026-07 · 119 · 103002
DOI: 10.1016/j.bcmd.2026.103002 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Blood Cells, Molecules, and Diseases, 2026-07. Verfasst von Sandhya Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, 201303, India. Electronic address: guptas2091@gmail.com. Hauptthemen laut MEDLINE: Menorrhagia, Hemorrhagic Disorders, Blood Coagulation Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Heavy menstrual bleeding (HMB) a common manifestation of bleeding disorders in adolescents contributes to anemia, transfusions, and impaired quality-of-life (QOL). Evidence supporting practical management strategies in resource-limited settings remains limited. METHODS This observational study in adolescents with confirmed bleeding disorders with HMB at a tertiary hemophilia treatment centre evaluated menstrual blood loss and QOL after a standard regimen of progesterone, tranexamic acid and iron; blood products or clotting factor concentrates were reserved for refractory bleeding. RESULTS Twenty adolescents were included (2020-2025); von Willebrand disease (n = 11), chronic immune thrombocytopenia (n = 4), congenital aplastic anemia (n = 3), afibrinogenemia (n = 1), and factor VII deficiency (n = 1). Median PBAC score at presentation was 300 (range 190-500). Eighteen patients (90%) had anemia and prior transfusion exposure. After therapy, median PBAC declined to 100 (range 60-150). Hemoglobin improved steadily and no patient required further red cell transfusion during a median follow-up of four years. Hemostatic products were required only in two patients while on this regimen. Quality-of-life scores improved across physical, emotional, and social domains. CONCLUSIONS A low-cost regimen combining progesterone, antifibrinolytic therapy, and iron effectively controls HMB, corrects anemia, reduces transfusion and factor utilization, and improves QOL in adolescents with bleeding disorders in resource-constrained settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, 201303, India. Electronic address: guptas2091@gmail.com.
- Department of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, 201303, India. Electronic address: nitaradhakrishnan@yahoo.com.
- Department of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, 201303, India. Electronic address: archit10000@gmail.com.
- Department of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, 201303, India. Electronic address: anukritisr826@gmail.com.
Zitieren
APA
Gupta, S., Radhakrishnan, N., Pandharipande, A., & Srivastava, A. (2026). Managing heavy menstrual bleeding in adolescents with bleeding disorders: Outcomes from a pragmatic LMIC approach. Blood Cells, Molecules, and Diseases, 119, 103002. https://doi.org/10.1016/j.bcmd.2026.103002
Vancouver
Gupta S, Radhakrishnan N, Pandharipande A, Srivastava A. Managing heavy menstrual bleeding in adolescents with bleeding disorders: Outcomes from a pragmatic LMIC approach. Blood Cells, Molecules, and Diseases. 2026;119:103002. doi:10.1016/j.bcmd.2026.103002
BibTeX
@article{Gupta2026,
author = {Gupta, Sandhya and Radhakrishnan, Nita and Pandharipande, Archit and Srivastava, Anukriti},
title = {Managing heavy menstrual bleeding in adolescents with bleeding disorders: Outcomes from a pragmatic LMIC approach},
journal = {Blood Cells, Molecules, and Diseases},
year = {2026},
volume = {119},
pages = {103002},
doi = {10.1016/j.bcmd.2026.103002}
}
EUVIMED